Wed, Mar 4, 2015, 8:10 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Cytori Therapeutics, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • rhdapeng rhdapeng Aug 10, 2009 9:06 AM Flag

    Quarter results are VERY GOOD

    OK the one time payment from Olympus helps with the ongoing losses, BUT actual product revenues and gross profit are down Q/Q. So they are not selling much new.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • fyi-
      SAN DIEGO (AP) -- Cytori Therapeutics Inc., which makes products used in adult stem cell harvesting and research, on Monday reported a narrower loss for the second quarter of the year on a boost in development revenue.

      Cytori said it lost $826,000, or 2 cents per share, compared with a loss of $8.4 million, or 33 cents per share, a year earlier. Revenue jumped to $8.5 million from $1.4 million.

      Analysts expected a loss of 15 cents per share and $2.8 million in revenue, according to Thomson Reuters.

      The company makes a line of products called StemSource, which are used to extract, freeze and apply adult stem cells taken from fat tissue. Cytori also makes the Celbrush needle.

1.14-0.06(-5.00%)Mar 4 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Vivint Solar, Inc.
NYSEWed, Mar 4, 2015 4:01 PM EST
Wayfair Inc.
NYSEWed, Mar 4, 2015 4:02 PM EST